Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ezetimibe Plus Lifestyle in NASH
NCT01950884Phase 4Unknown
- Sponsor
- University of Palermo
- Start
- Oct 2013
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ezetimibe in Nonalcoholic steatohepatitis (NASH) (2 arms), sponsored by University of Palermo. Primary endpoint: Histological Improvement in the Severity of NASH at 52 weeks. Status: unknown.
02
Drugs
ezetimibe
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT01950884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01950884.